Compare MXC & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MXC | DYAI |
|---|---|---|
| Founded | 1972 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1M | 17.0M |
| IPO Year | 1995 | 2026 |
| Metric | MXC | DYAI |
|---|---|---|
| Price | $8.92 | $0.34 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.8K | ★ 84.0K |
| Earning Date | 11-20-2026 | 11-12-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | $2,705,235.00 | ★ $3,090,345.00 |
| Revenue This Year | N/A | $113.16 |
| Revenue Next Year | N/A | $94.92 |
| P/E Ratio | $36.33 | ★ N/A |
| Revenue Growth | ★ 7.12 | N/A |
| 52 Week Low | $7.16 | $0.34 |
| 52 Week High | $16.48 | $1.60 |
| Indicator | MXC | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 37.39 | 32.18 |
| Support Level | $8.74 | N/A |
| Resistance Level | $9.48 | $0.48 |
| Average True Range (ATR) | 0.50 | 0.03 |
| MACD | -0.12 | -0.00 |
| Stochastic Oscillator | 18.02 | 0.71 |
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.